A COMPARISON BETWEEN ENTERAL AND PARENTERAL METHOTREXATE INTAKE IN IRAQI PATIENTS WITH RHEUMATOID ARTHRITIS REGARDING EFFICACY AND LIVER FUNCTION IMPAIRMENT

Objectives: Methotrexate (MTX) is a disease-modifying ant-rheumatic drug that has been used commonly in patients with rheumatoid arthritis (RA) with a goal of reducing RA activity or RA remission. Response to MTX varied among patients and side effects including liver impairment are not uncommon. The...

Full description

Saved in:
Bibliographic Details
Published inAsian journal of pharmaceutical and clinical research pp. 51 - 53
Main Author AL-TUMA, ALI M KADHIM
Format Journal Article
LanguageEnglish
Published 07.06.2024
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first